Sanofi vs Stryker

Sanofi (SNY), health care, and Stryker (SYK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Stryker is worth $120.1B on the stock market and Sanofi $115B: Stryker is valued at 4% more. Sanofi trades at 23.8 times earnings and Stryker at 33.6; operating margins in their latest fiscal years were 14.5% and 19.5%. Over the past year Sanofi's share price has moved -4.48% and Stryker's -13.6%.

Key facts

Sanofi market value
$115B
Stryker market value
$120.1B
Sanofi P/E
23.8
Stryker P/E
33.6
Sanofi revenue
$48.4BFY to 2025-12-31
Stryker revenue
$25.1BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Sanofi vs Stryker: every measure side by side
Measure Sanofi Stryker
SectorHealth CareHealth Care
Country France United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$115Blower$120.1Bhigher
Revenue$48.4Bhigher$25.1Blower
Earnings$8.7Bhigher$3.2Blower
Employees74,846higher56,000lower
Total assets$140.7Bhigher$47.8Blower
Valuation
P/E23.8lower33.6higher
P/S2.4lower4.8higher
P/B—5.1
Dividend yield—1.13%
Profitability
Operating margin14.5%lower19.5%higher
Balance sheet
Net assets$79.2Bhigher$22.4Blower
Total liabilities$61.1Bhigher$25.4Blower
Total debt$20.8Bhigher$15.9Blower
Cash on hand$8.5Bhigher$4Blower
Price change
Today-1.05%lower+1.53%higher
1 year-4.48%higher-13.6%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio. Who owns SNY · Who owns SYK

Further comparisons

Learn

Questions and answers

Which is bigger, Sanofi or Stryker?

By market value, Stryker is the larger: $120.1B against $115B for Sanofi. By revenue in its latest fiscal year, Sanofi is the larger: $48.4B against $25.1B for Stryker.

Which has the higher P/E ratio?

Stryker: 33.6, against 23.8 for Sanofi. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Stryker: 19.5%, against 14.5% for Sanofi. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has more debt?

Sanofi: $20.8B, against $15.9B for Stryker. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Sanofi and Stryker?

None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Sanofi and 8 hold Stryker.

Cite this page

Funkfolio, “Sanofi vs Stryker”, data as of 17 November 2026. https://funkfolio.com/compare/sny-vs-syk

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.